Vielight
Vielight is a Canadian developer of home-use brain and systemic photobiomodulation (PBM) devices, including the transcranial and intranasal Vielight Neuro technology.
Last updated September 16, 2026
AI crawler reads
2requests
1companies- Anthropic2
- Profile
- 2
- Controversies
- 0
- JSON · MD
- 0
- First read
- Nov 4, 2026
- Latest read
- Nov 4, 2026
From this site's server log
Overview
Vielight Inc. develops home-use photobiomodulation (PBM) technology for brain and systemic health. Since 2010 the company states it has worked on advanced home-use PBM technology and scientific research in brain health, and it says it invented transcranial brain photobiomodulation (tPBM) and intranasal photobiomodulation (iPBM). Its intranasal-transcranial brain PBM (itPBM) technology, the Vielight Neuro, is described as having demonstrated efficacy in independent PBM clinical trials with over 800 clinical research participants in published trials. The company states its devices are FDA and Health Canada registered medical devices, and that its manufacturing and quality systems are certified to ISO 13485:2016, IEC 62471 and MDSAP standards. Its product line includes the Neuro Pro 2, Neuro Gamma 4 and Neuro Duo 4 brain-stimulation devices, and the Vielight RX-Plus, which holds a Health Canada medical device license for accelerating recovery of upper respiratory symptoms in viral infections such as COVID-19.
History
Vielight Inc. states that since 2010 it has empowered individuals with advanced home-use photobiomodulation (PBM) technology while driving scientific breakthroughs in brain health and beyond. Over a decade ago, the company says it invented transcranial brain photobiomodulation (tPBM) and intranasal photobiomodulation (iPBM). Its intranasal-transcranial brain PBM (itPBM) technology, the Vielight Neuro, is described as having demonstrated efficacy in the most independent PBM clinical trials for challenging conditions, with over 800 clinical research participants in published clinical trials to date. The company describes itself as the original inventor of brain photobiomodulation and states it leads the industry with the largest utility patent portfolio, spanning Artificial Intelligence (AI)-based neuromodulation to intranasal-transcranial brain and vagus nerve photobiomodulation. Vielight states it works alongside leading researchers and clinicians worldwide, with a core team of neuroscientists, medical doctors and photonics engineers. It states that Vielight Inc. has FDA and Health Canada registered medical devices, and that its manufacturing and quality systems are built to meet international quality management and safety standards, certified to ISO 13485:2016, IEC 62471 and MDSAP standards. The company also states its technology has been featured in the most Alzheimer's, MCI, Traumatic Brain Injury and Human Enhancement (PBM) studies, supported by a dedicated team of PhD researchers and a network of research institutions. On its homepage, Vielight describes a decade of engineering and clinical research, from NFL teams to NASCAR, and states that the Vielight Neuro won a $4.6M US Department of Defense grant, expanding on published neuroprotection imaging research with the University of Utah. It also reports 100,000+ devices sold worldwide to home users, practitioners and athletes, and a 4.7/5 rating based on 472 reviews. A January 2024 blog post describes a major viral recovery clinical trial (n=294) conducted with the Vielight RX-Plus, and states that the Vielight RX-Plus is the only PBM device supported by published clinical results for viral recovery and inflammatory-based immunity (September 2024), with a Health Canada medical device license indication to accelerate the recovery of upper respiratory symptoms in viral infections such as COVID-19.
Products and positioning
Home-use brain and systemic photobiomodulation devices described as the most researched PBM technology, driven by science and clinical research.
Neuro Pro 2
Described as the world's most powerful and customizable brain-stimulation PBM device.
Neuro Gamma 4
Described as next-gen neurotech supporting sharper focus, memory and mental clarity.
Neuro Duo 4
Described as a best seller with two modes: sharp focus and memory by day, deep calm by night.
Vielight RX-Plus
Holds a Health Canada medical device license to accelerate recovery of upper respiratory symptoms in viral infections such as COVID-19.
Sources4 sources
- 1Vielight Photobiomodulation Therapy Devices | At-Home Brain PBMvielight.com
- 2Promoting brain health - Vielight Incvielight.com
- 3What is Photobiomodulation? - Vielight Incvielight.com
- 4Viral and Immunity Recovery Results: Vielight Major Clinical Trial (n=294) - Health Canada Medical Device License - Vielight Incvielight.com
Cite this profile: Cite the canonical profile. /brand-wiki/vielight · Editorial policy · How profiles are compiled